The use of genetically humanized animal models for personalized medicine approaches
For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the d...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2020-02-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/13/2/dmm041673 |
id |
doaj-9a55427efd994412af34cf2720b2636b |
---|---|
record_format |
Article |
spelling |
doaj-9a55427efd994412af34cf2720b2636b2020-11-24T22:10:28ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112020-02-0113210.1242/dmm.041673041673The use of genetically humanized animal models for personalized medicine approachesAnnemieke Aartsma-Rus0Maaike van Putten1Annemieke Aartsma-Rus2James Dowling3Maaike van Putten4 Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the development of personalized medicine approaches; however, given that they target human mutations and therefore human genetic sequences, scientists rely on the availability of humanized animal models. Here, we outline the usefulness, caveats and potential of such models, using the example of the hDMDdel52/mdx model, a humanized model recently generated for Duchenne muscular dystrophy (DMD).http://dmm.biologists.org/content/13/2/dmm041673genetic therapiesgenome editingexon skippingpre-clinical studiesmuscular dystrophy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Annemieke Aartsma-Rus Maaike van Putten Annemieke Aartsma-Rus James Dowling Maaike van Putten |
spellingShingle |
Annemieke Aartsma-Rus Maaike van Putten Annemieke Aartsma-Rus James Dowling Maaike van Putten The use of genetically humanized animal models for personalized medicine approaches Disease Models & Mechanisms genetic therapies genome editing exon skipping pre-clinical studies muscular dystrophy |
author_facet |
Annemieke Aartsma-Rus Maaike van Putten Annemieke Aartsma-Rus James Dowling Maaike van Putten |
author_sort |
Annemieke Aartsma-Rus |
title |
The use of genetically humanized animal models for personalized medicine approaches |
title_short |
The use of genetically humanized animal models for personalized medicine approaches |
title_full |
The use of genetically humanized animal models for personalized medicine approaches |
title_fullStr |
The use of genetically humanized animal models for personalized medicine approaches |
title_full_unstemmed |
The use of genetically humanized animal models for personalized medicine approaches |
title_sort |
use of genetically humanized animal models for personalized medicine approaches |
publisher |
The Company of Biologists |
series |
Disease Models & Mechanisms |
issn |
1754-8403 1754-8411 |
publishDate |
2020-02-01 |
description |
For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the development of personalized medicine approaches; however, given that they target human mutations and therefore human genetic sequences, scientists rely on the availability of humanized animal models. Here, we outline the usefulness, caveats and potential of such models, using the example of the hDMDdel52/mdx model, a humanized model recently generated for Duchenne muscular dystrophy (DMD). |
topic |
genetic therapies genome editing exon skipping pre-clinical studies muscular dystrophy |
url |
http://dmm.biologists.org/content/13/2/dmm041673 |
work_keys_str_mv |
AT annemiekeaartsmarus theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT maaikevanputten theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT annemiekeaartsmarus theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT jamesdowling theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT maaikevanputten theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT annemiekeaartsmarus useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT maaikevanputten useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT annemiekeaartsmarus useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT jamesdowling useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches AT maaikevanputten useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches |
_version_ |
1725807907507798016 |